Pancreatic Cancer Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with pancreatic cancer (a specific type called adenocarcinoma) that has not spread to other parts of the body, and cannot be removed by surgery straight away (classified as "borderline" or "locally advanced")
- You have not yet had any surgery or chemotherapy treatment for this cancer
- You are over 18 years old
- Your general health is good enough to receive medical treatment or undergo surgery (confirm with trial site)
- You are being treated or managed at the Paoli-Calmettes Institute
- You are willing to sign a consent form specific to this study (called PANDORE-PANC)
- You are covered by a social security or health insurance system in France
Who may not be able to join:
- Your cancer has already spread to other parts of the body (metastatic disease)
- Your pancreatic tumor is a different type of cancer, not adenocarcinoma
- You have another cancer that is currently being treated, or for which treatment finished less than 1 year ago
- You are pregnant or breastfeeding
- You are in an emergency medical situation at the time of enrolment
- You are an adult who is under a legal protection order (such as guardianship or curatorship), or you are unable to give your own consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33491223778
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Predict response to systemic therapies in patients with non-metastatic pancreatic adenocarcinoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.